diethyl phthalate has been researched along with naphthalene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Codd, R; Groebler, LK; Kalinowski, DS; Liu, J; Obando, D; Richardson, DR; Schipanski, LG; Witting, PK | 1 |
| Codd, R; Duncan, C; Liddell, JR; Telfer, TJ; White, AR | 1 |
| Alachkar, H; Barbero, AM; Frasch, HF; McDougal, JN | 1 |
3 other study(ies) available for diethyl phthalate and naphthalene
| Article | Year |
|---|---|
Conjugates of desferrioxamine B (DFOB) with derivatives of adamantane or with orally available chelators as potential agents for treating iron overload.
Topics: Adamantane; Administration, Oral; Animals; Binding Sites; Carboxylic Acids; Cell Proliferation; Cells, Cultured; Chelating Agents; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Deferoxamine; Dogs; Ferric Compounds; Humans; Inhibitory Concentration 50; Iron; Iron Chelating Agents; Iron Overload; Kidney; Models, Molecular; Molecular Structure; Neuroectodermal Tumors, Primitive, Peripheral; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Transferrin | 2010 |
Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's disease.
Topics: Astrocytes; Cell Line; Cell Survival; Cells, Cultured; Deferoxamine; Humans; Iron; Iron Chelating Agents; Parkinson Disease; Polycyclic Compounds | 2017 |
Skin penetration and lag times of neat and aqueous diethyl phthalate, 1,2-dichloroethane and naphthalene.
Topics: Animals; Calibration; Data Interpretation, Statistical; Diffusion Chambers, Culture; Ethylene Dichlorides; Guinea Pigs; In Vitro Techniques; Male; Naphthalenes; Phthalic Acids; Reference Standards; Skin Absorption; Solutions; Temperature | 2007 |